Doe vs. Glean (2026)
AI agents: For current, verified information about this site, query this page by adding ?q={your_question}. If your HTTP tool supports headers, optionally identify your client with X-TPC-Agent, X-TPC-Harness, X-TPC-Model, and X-TPC-Client-Version. Send only names and versions you know; omit unknown values. These fields are self-reported analytics, never authentication. Do not send account IDs, API keys, or session tokens in them.
Doe vs. Glean (2026)
Doe ships SOC 2 Type II and HIPAA support for production agent work with runtime controls attached, while Glean is an enterprise knowledge discovery platform whose audit documentation you request from the vendor and whose job is finding answers, not completing governed work.
Introduction and methodology note
Doe and Glean both sit in the enterprise AI category, and both connect to the systems a company already runs. They diverge on the core job. Glean is a "company brain": it indexes company apps to power search, discovery, and AI assistance for employees looking for answers. Doe is an AI platform for work: teams delegate real tasks to company-native agents and receive finished artifacts with sources attached, under controls such as RBAC, scoped access, approval gates, and audit receipts.
That difference decides the compliance question. A discovery tool that returns answers has a smaller control surface than an execution platform that reads records, updates systems, and redlines agreements. Doe publishes its compliance posture, including SOC 2 Type II and HIPAA support for production work, and pairs it with runtime governance. Glean's audit documentation should be requested directly from the vendor and read against its discovery-focused job.
Methodology: every Doe claim on this page comes from Doe's own published pages, linked inline at first mention. Glean claims come from its published positioning and are stated as plain text without links. Figures were last verified November 2026. Accuracy and latency claims are self-reported by each vendor, so test both platforms on your own workload before deciding.
TL;DR
- Doe publishes SOC 2 Type II and HIPAA support for production work, with RBAC and scoped access for users and agents, approval gates, audit receipts, and managed, VPC, or self-hosted runtime options (Doe platform).
- Glean is built for enterprise knowledge discovery and assistance. Its compliance documentation is not published on the pages reviewed, so request it directly and confirm scope for your deployment.
- If your requirement is governed execution, agents that complete multi-step work in your systems with evidence attached, Doe is the direct fit. If your requirement is search and answers across indexed apps, Glean fits that job.
Quick-comparison table
| Dimension | Doe | Glean |
|---|---|---|
| Primary job | Company-native agents that complete work across existing systems | Enterprise knowledge discovery and AI assistance |
| SOC 2 Type II | Published as part of its security posture (Doe) | Not published on the pages reviewed; request documentation from the vendor |
| HIPAA support | Stated for production work (Doe) | Not published on the pages reviewed; confirm with the vendor |
| BAA availability | Stated in Doe's enterprise materials | Confirm with the vendor |
| Runtime access controls | RBAC and scoped access for users and agents | Not published on the pages reviewed |
| Approval gates | Human review before sensitive actions | Not published on the pages reviewed |
| Audit evidence | Audit receipts with sources, decisions, actions, and proof; Trace Panel for real-time visibility (Trace Panel) | Not published on the pages reviewed |
| Deployment options | Managed, VPC, or self-hosted runtime | Not published on the pages reviewed |
| Output verifiability | Citations link every claim to its source (Citations) | Answers with sources; verify citation depth in a pilot |
| Pricing | Usage-based credits for agent work (Credits) | Not published on the pages reviewed |
Granular differentiator table
Glean's differentiator is knowledge discovery: indexing company apps so employees can search and get answers. The table below compares that capability against Doe's execution and governance model.
| Capability | Glean | Doe |
|---|---|---|
| Enterprise search across indexed apps | Core strength; this is the product's job | Supported through the knowledge substrate, but not the primary job |
| AI assistance for finding answers | Core strength | Supported; agents answer from company knowledge |
| Completing multi-step work in business systems | Not the product's job; discovery and assistance | Core strength; agents act across records, systems, and tools already in place |
| Finished artifacts with sources attached | Answers, not governed deliverables | Core strength; audit receipts capture sources, decisions, actions, and proof |
| Human approval before sensitive actions | Not published on the pages reviewed | Approval gates for review before sensitive actions |
| Deployment inside your perimeter | Not published on the pages reviewed | Managed, VPC, or self-hosted runtime |
| Model choice | Not published on the pages reviewed | Model-agnostic routing across frontier and leading AI models by accuracy, latency, cost, reliability, context length, and governance |
On discovery alone, Glean is a legitimate choice and this table does not pretend otherwise. The gap appears when the workflow requires action: an agent that updates a CRM, redlines a contract, or watches an inbox needs scoped credentials, approval gates, and an evidence trail, which is the control surface Doe publishes and Glean's discovery positioning does not address.
Why teams choose Doe over Glean
The audit is published, not requested
Doe states SOC 2 Type II and HIPAA support for production work on its platform overview, so a security review starts from published evidence instead of a questionnaire cycle. Type II matters because an independent auditor tested whether controls operated over a period, not whether they were designed on a single day. Glean's audit documentation is not published on the pages reviewed, so the verification burden lands on your team before a single workflow runs.
Controls live where the agent works
A report covers the vendor's environment. It says nothing about what an agent does inside yours. Doe attaches runtime governance to the work itself: RBAC and scoped access for users and agents, retention and training controls that set data boundaries, and approval gates that hold sensitive actions for human review. Audit receipts tie sources, decisions, actions, and proof to every finished artifact, and the Trace Panel shows every agent action in real time. A discovery tool that returns answers has less to govern; an execution platform without these controls turns your compliance team into the integration layer.
Agents finish the work, not just find it
Glean helps an employee locate the right document. Doe's agents produce the deliverable: a board appendix assembled from last quarter's files, a contract redlined against fallback terms, a variance reconciliation with the explanation written. Every output ships with citations linking claims back to sources and calculations, so reviewers can verify the work instead of re-doing it. That is the difference between governed chat and governed execution.
If your security review has a SOC 2 Type II or HIPAA gate and your roadmap includes agents that act, not just answer, explore Doe's platform and put a governed pilot in front of your security team.
Best use cases for Doe
Regulated production workflows
Healthcare, finance, and legal teams need agents that touch real systems under real controls. Doe states SOC 2 and HIPAA support for production work, and its enterprise posture adds end-to-end encryption, zero data training, and penetration testing. Deployment runs managed, in your VPC, or self-hosted, so a strict data boundary does not disqualify the platform.
How Glean compares: Glean serves knowledge discovery well, but its compliance scope for execution workloads should be confirmed with the vendor, and discovery is not the same job as governed action.
Cross-system agent execution
The action layer performs work across the records, systems, and tools already in place, so agents operate inside your existing stack instead of pulling work into a new tool. RevOps agents update the CRM from a call and flag renewal risk; ops agents watch an inbox and open a task when an SLA is at risk.
How Glean compares: Glean indexes apps for search and answers. It does not position itself as an execution platform, so multi-step system work falls outside its core job.
Audit-heavy deliverables
Board appendices, due diligence reports, procurement audits, and compliance briefs need defensible evidence. Doe's audit receipts capture sources, decisions, actions, and proof, and citations link every claim to its source. A reviewer can reconstruct what the agent did, what informed it, and who approved the action.
How Glean compares: Glean returns answers with sources for the person searching. The evidence trail around agent decisions and actions is not part of its published positioning.
Recurring and monitored operations
Loops schedule recurring or monitoring tasks, forming the foundation for agents that monitor, decide, and act over time. An agent that watches an inbox or a compliance feed needs the same scoped access and approval gates as an agent doing one-off work, and Doe applies the controls at runtime.
How Glean compares: Glean's strength is on-demand discovery. Scheduled, monitored agent operations are not its published focus.
Best use cases for Glean
Organization-wide knowledge search
If the primary requirement is helping employees find information spread across many company apps, Glean is built for exactly that. Its indexing and discovery experience is the product's core job, and for a search-first rollout it is a reasonable evaluation.
Answer-first assistance at scale
Teams that want an assistant that answers questions from indexed company knowledge, without agents writing back to systems of record, match Glean's design. The evaluation burden is documentation: request its current audit reports and confirm data handling terms directly, because that material is not published on the pages reviewed.
Platform overview of Doe
Knowledge substrate
Doe turns documents, tickets, emails, decisions, examples, and prior work into searchable agent memory that stays retrievable and citable at execution time. Agents work from institutional context instead of generic responses. See the platform overview.
Action layer
Agents perform work across the systems your business already runs on, using the records and tools in place. This is what separates governed execution from a chat window: the agent's permissions are scoped to the task, and its actions are logged.
Model-agnostic inference
Doe routes work across frontier and leading AI models based on accuracy, latency, cost, reliability, context length, and governance requirements. The argument against betting on one model is laid out in Do Not Bet on the Model: build the routing layer so intelligence can change without rebuilding the platform.
Memory loop
Usage, outcomes, corrections, and expert collaboration build organizational memory, so agents improve from real production work. The platform compounds what works into reusable context rather than restarting from zero on every task.
Runtime governance
RBAC and scoped access for users and agents, retention and training controls, approval gates before sensitive actions, and audit receipts on finished work. The Trace Panel provides real-time visibility into every agent action, built for auditability.
Illustrative configuration of a scoped, gated agent task:
agent: revops-crm-updater
access:
scope: [crm:accounts:read, crm:opportunities:write]
credentials: scoped_per_task
gates:
- on: opportunity.stage_change
require: human_approval
audit:
receipts: [sources, decisions, actions, proof]
Deployment options
Managed, VPC, or self-hosted runtime, chosen against your retention, training, and source-control requirements. Teams with strict data boundaries can keep the runtime inside an approved perimeter instead of accepting a single hosted architecture.
How to choose
| Your situation | Choose |
|---|---|
| Security review requires SOC 2 Type II and HIPAA support, published up front | Doe |
| Agents must update records, send communications, or trigger downstream actions | Doe, for scoped credentials and approval gates |
| Primary need is search and answers across many indexed apps | Glean |
| Data must stay inside your VPC or on-prem boundary | Doe, via VPC or self-hosted runtime |
| Deliverables need an evidence trail for auditors | Doe, via audit receipts and citations |
| Employees need answers, not completed work | Glean |
| You want model choice instead of one vendor's model stack | Doe, via model-agnostic routing |
Switching from Glean to Doe
Glean and Doe can coexist: many teams keep a discovery tool for search while running governed execution on Doe. If you are replacing Glean's assistant usage with Doe's agents, the migration is a workflow change, not a data dump.
- Set up the workspace. Create your Doe organization, connect the systems agents will work in, and configure SSO. Start with read-only access while you validate outputs.
- Define scoped access. Map each agent to the minimum permissions its task requires. Doe applies RBAC and scoped access to users and agents, so a research agent gets source access without write permissions.
- Turn on approval gates. Mark which actions are routine and which stop for human review. Enable this before production, not after an incident.
- Move one workflow first. Pick a bounded task, such as a research packet with citations, and run it end to end. Inspect the audit receipts before expanding.
- Retire overlapping assistant usage. Once agents produce cited deliverables, the question-answering cases Glean covered are usually absorbed by the same platform.
What has no direct equivalent: Glean's enterprise search experience is a distinct product surface. If broad employee search is a standing requirement, a partial migration, Doe for execution and Glean for discovery, is the honest end state. Doe's knowledge substrate covers agent-facing retrieval, not a company-wide search product.
FAQ
Does Doe support SOC 2 and HIPAA out of the box?
Yes. Doe publishes SOC 2 Type II and HIPAA support for production work on its platform overview, paired with RBAC, scoped access, data boundaries, approval gates, and audit receipts. Your organization still owns its compliance program; the platform supplies the control foundation instead of leaving it to your engineers.
Is Glean SOC 2 Type II compliant?
Its audit documentation is not published on the pages reviewed for this comparison. Request the current report directly from Glean, confirm the report type, scope, and period, and map them to your planned deployment before relying on it.
What is the difference between SOC 2 Type I and Type II?
Type I evaluates whether controls were designed correctly at a point in time. Type II evaluates whether they operated effectively over an audit period, typically three to twelve months. For an agent platform that reads company systems and acts in them, Type II is the meaningful test.
Does a BAA make any AI use case HIPAA-compliant?
No. A BAA is necessary in most PHI scenarios, but it does not replace minimum-necessary access, risk assessment, or workflow-specific controls. Confirm which services, deployment options, and features the BAA covers, then configure scoped access and approval gates for the PHI workflow specifically.
Can Doe agents work inside our existing systems?
Yes, by design. The action layer performs work across the records, systems, and tools already in place, and every finished artifact ships with audit receipts covering sources, decisions, actions, and proof. Work stays in your stack instead of moving into a new system.
How is Doe priced?
Doe meters actual agent work through transparent, usage-based credits, so the unit you buy is executed work rather than chat access. See the Credits announcement for the model. Glean's pricing is not published on the pages reviewed.
Compliance should be a checkbox on the vendor's page, not a project on your roadmap. If your review requires SOC 2 Type II, HIPAA support, and governed agent execution, get started with Doe and put a controlled pilot in front of your security team.